scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1530-0277.2000.TB04585.X |
P698 | PubMed publication ID | 10698366 |
P2093 | author name string | Li TK | |
Corrigall WA | |||
Harding JW | |||
Lê AD | |||
Juzytsch W | |||
P2860 | cites work | Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells | Q24537213 |
Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro | Q29040030 | ||
Do rat strain differences in ethanol consumption reflect differences in ethanol sensitivity or the preparedness to learn? | Q30233898 | ||
The effects of nicotine on locomotor activity in non-tolerant and tolerant rats | Q36097530 | ||
Alcohol or tobacco research versus alcohol and tobacco research | Q37909088 | ||
Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis | Q41351009 | ||
The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity | Q42710031 | ||
Chronic nicotine and locomotor activity: influences of exposure dose and test dose | Q43616826 | ||
Responses to cholinergic agonists of rats selectively bred for differential sensitivity to ethanol | Q43829310 | ||
Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens | Q43915028 | ||
Nicotine maintains robust self-administration in rats on a limited-access schedule | Q44290531 | ||
Intracerebellar nicotinic-cholinergic participation in the cerebellar adenosinergic modulation of ethanol-induced motor incoordination in mice | Q48138333 | ||
Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area | Q48207895 | ||
Central behavioral interactions between ethanol, (-)-nicotine, and (-)-cotinine in mice | Q48375471 | ||
Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area | Q48435230 | ||
Ethanol-induced locomotor activity: involvement of central nicotinic acetylcholine receptors? | Q48447554 | ||
Sensitization of the mesoaccumbens dopamine response to nicotine | Q48469856 | ||
Adrenalectomy attenuates nicotine-induced dopamine release and locomotor activity in rats | Q48846452 | ||
Ethanol-nicotine interactions in long-sleep and short-sleep mice | Q48924760 | ||
Effects of N-methyl-D-aspartate receptor antagonists on reinforced and nonreinforced responding for ethanol in rats. | Q52174971 | ||
Blockade of nicotine self-administration with nicotinic antagonists in rats. | Q52177843 | ||
An oral self-administration model of nicotine preference in rats: effects of mecamylamine. | Q52198694 | ||
P and NP rats respond differently to the discriminative stimulus effects of nicotine. | Q52224797 | ||
Nicotine-induced potentiation of ethanol discrimination | Q69499579 | ||
Acute and chronic tolerance to nicotine measured by activity in rats | Q69557254 | ||
Mecamylamine is a selective non-competitive antagonist of N-methyl-D-aspartate- and aspartate-induced currents in horizontal cells dissociated from the catfish retina | Q70258614 | ||
Alcohol consumption in free-feeding rats: procedural, genetic and pharmacokinetic factors | Q70346349 | ||
Ethanol intake increases during continuous administration of amphetamine and nicotine, but not several other drugs | Q71776637 | ||
Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats | Q71854848 | ||
Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment | Q71865726 | ||
The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine | Q72723449 | ||
Exposure to nicotine enhances acquisition of ethanol drinking by laboratory rats in a limited access paradigm | Q77402421 | ||
Involvement of CNS cholinergic systems in alcohol drinking of P rats | Q87022750 | ||
P433 | issue | 2 | |
P304 | page(s) | 155-163 | |
P577 | publication date | 2000-02-01 | |
P1433 | published in | Alcoholism: Clinical and Experimental Research | Q4713331 |
P1476 | title | Involvement of nicotinic receptors in alcohol self-administration. | |
P478 | volume | 24 |
Q28068256 | A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction |
Q30412161 | A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence |
Q50518972 | Acquisition and reinstatement of ethanol-induced conditioned place preference in rats: Effects of the cholinesterase inhibitors donepezil and rivastigmine. |
Q51834407 | Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of exposure to stress and modulation by mecamylamine. |
Q34137278 | Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption |
Q31924014 | Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function |
Q27345275 | Alcohol and nicotine interactions: pre-clinical models of dependence |
Q33853981 | Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism |
Q34610366 | Biological processes underlying co-use of alcohol and nicotine: neuronal mechanisms, cross-tolerance, and genetic factors. |
Q35045139 | Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. |
Q73222727 | Caffeine promotes ethanol drinking in rats. Examination using a limited-access free choice paradigm |
Q37259110 | Chemistry and pharmacological studies of 3-alkoxy-2,5-disubstituted-pyridinyl compounds as novel selective α4β2 nicotinic acetylcholine receptor ligands that reduce alcohol intake in rats |
Q35423832 | Chronic nicotine activates stress/reward-related brain regions and facilitates the transition to compulsive alcohol drinking |
Q34554630 | Cigarette smoke exposure greatly increases alcohol consumption in adolescent C57BL/6 mice |
Q36692865 | Cigarettes and alcohol: The influence of nicotine on operant alcohol self-administration and the mesolimbic dopamine system |
Q33942653 | Co-morbidity of smoking in patients with psychiatric and substance use disorders |
Q42371322 | Coadministration of intravenous nicotine and oral alcohol in rats |
Q34623008 | Combined exposure to nicotine and ethanol in adolescent mice differentially affects anxiety levels during exposure, short-term, and long-term withdrawal. |
Q94011621 | Concurrent Alcohol and Tobacco Dependence: Mechanisms and Treatment |
Q34407185 | Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models |
Q36372867 | Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse |
Q36877440 | Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers |
Q43717669 | Differences in nicotine-induced dopamine release and nicotine pharmacokinetics between Lewis and Fischer 344 rats |
Q48930829 | Different Hypothalamic Nicotinic α7 Receptor Expression and Response to Low Nicotine Dose in Alcohol-Preferring and Alcohol-Avoiding Rats |
Q50942768 | Differential effects of nicotine on alcohol consumption in men and women. |
Q41929123 | Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake |
Q52639267 | Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs. |
Q35163401 | Drinking motives in female smokers: factor structure, alcohol dependence, and genetic influences |
Q33820862 | Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration |
Q33709932 | Effects of mecamylamine on alcohol consumption and preference in male C57BL/6J mice |
Q43921723 | Effects of nicotine on alcohol intake in a rat model of depression |
Q36963775 | Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats |
Q46261665 | Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior |
Q38870727 | Effects of varenicline on alcohol self-administration and craving in drinkers with depressive symptoms |
Q35892732 | Enhanced alcohol-seeking behavior by nicotine in the posterior ventral tegmental area of female alcohol-preferring (P) rats: modulation by serotonin-3 and nicotinic cholinergic receptors |
Q58609160 | Ethanol→Nicotine & Nicotine →Ethanol Drug-Sequence Discriminations: Conditional Stimulus Control with Two Interoceptive Drug Elements in Rats |
Q35994511 | Heavy-Drinking Smokers' Treatment Needs and Preferences: A Mixed-Methods Study |
Q46935426 | Increased vulnerability to nicotine self-administration and relapse in alcohol-naive offspring of rats selectively bred for high alcohol intake. |
Q35062485 | Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications |
Q38824915 | Interactions between nicotine and drugs of abuse: a review of preclinical findings |
Q34558819 | Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake |
Q62729760 | Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking |
Q33859960 | Mechanisms and genetic factors underlying co-use of nicotine and alcohol or other drugs of abuse |
Q37519956 | Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders |
Q38718932 | Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models |
Q30475871 | Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice |
Q37467418 | Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice |
Q44080843 | Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors |
Q37473457 | Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders |
Q34342747 | Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence |
Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
Q90190112 | Nicotine Gateway Effects on Adolescent Substance Use |
Q35748436 | Nicotine and ethanol co-use in Long-Evans rats: Stimulatory effects of perinatal exposure to a fat-rich diet |
Q30842705 | Nicotine enhances alcohol intake and dopaminergic responses through β2* and β4* nicotinic acetylcholine receptors. |
Q44283841 | Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats |
Q35903781 | Nicotine modulates alcohol-seeking and relapse by alcohol-preferring (P) rats in a time-dependent manner |
Q48582296 | Nicotine-induced enhancement of Pavlovian alcohol-seeking behavior in rats |
Q35591662 | Nicotinic acetylcholine receptors containing α6 subunits contribute to alcohol reward-related behaviours |
Q51977924 | Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues. |
Q28087047 | Nicotinic receptor modulation to treat alcohol and drug dependence |
Q37709823 | Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse |
Q34661812 | Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats |
Q35287506 | Pharmacological stress is required for the anti-alcohol effect of the α3β4* nAChR partial agonist AT-1001 |
Q36684437 | Pharmacotherapy for alcohol use disorder: current and emerging therapies |
Q36039402 | Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review. |
Q34359231 | Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system |
Q36949979 | Potential therapeutic uses of mecamylamine and its stereoisomers |
Q37699703 | Psychopharmacology of Tobacco and Alcohol Comorbidity: a Review of Current Evidence |
Q30853979 | Re-exposure to nicotine-associated context from adolescence enhances alcohol intake in adulthood. |
Q36581617 | Recent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism |
Q35184641 | Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. |
Q44177744 | Repeated nicotine injections decrease operant ethanol self-administration |
Q42794549 | Rimonabant attenuates sensitization, cross-sensitization and cross-reinstatement of place preference induced by nicotine and ethanol |
Q44292703 | Role of different nicotinic acetylcholine receptors in mediating behavioral and neurochemical effects of ethanol in mice |
Q30487079 | Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. |
Q51972404 | The effects of nicotine on locomotor activity and dopamine overflow in the alcohol-preferring AA and alcohol-avoiding ANA rats. |
Q37276928 | The influence of mecamylamine on ethanol and sucrose self-administration |
Q51363792 | The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. |
Q47550611 | The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption |
Q33949792 | The predicted impact of reducing the nicotine content in cigarettes on alcohol use |
Q36208644 | The relationship between rs3779084 in the dopa decarboxylase (DDC) gene and alcohol consumption is mediated by drinking motives in regular smokers |
Q43899406 | The relationship between smoking, drinking, and adolescents' self-perceived health and frequency of hospitalization: analyses from the 1997 National Household Survey on Drug Abuse |
Q37514878 | The α5 neuronal nicotinic acetylcholine receptor subunit plays an important role in the sedative effects of ethanol but does not modulate consumption in mice |
Q36111599 | The α6 nicotinic acetylcholine receptor subunit influences ethanol-induced sedation |
Q30442195 | The β2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse |
Q36746829 | Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice |
Q50877680 | Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats. |
Q33929766 | Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens |
Q33825408 | Varenicline reduces alcohol self-administration in heavy-drinking smokers |
Q35046256 | Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats |
Q30502320 | Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking |
Q39656764 | Voluntary co-consumption of alcohol and nicotine: Effects of abstinence, intermittency, and withdrawal in mice |
Search more.